1. Opening Hook

If chemistry had a LinkedIn page, Acutaas Chemicals just updated its headline to “Now hiring: Batteries, Semiconductors & Global Ambition.” The once humble pharma-intermediate maker is now flirting with Korean tech partners and lithium-ion dreams — all while casually doubling profits.
Revenue’s exploding, margins are glowing, and CMD Naresh Patel now sounds like he’s auditioning for Breaking Bad: Season Corporate.
Stay tuned — they’ve got solar plants powering reactors, Koreans funding fabs, and CFOs flexing working capital like gym bros with spreadsheets. 🔥

2. At a Glance

• Revenue ₹306 Cr (+24%) – Chemistry’s on steroids; everything grew except modesty.
• EBITDA ₹95 Cr (+2x YoY) – When molecules align, margins follow.
• PAT ₹72 Cr (+91%) – Profits so shiny they need lab goggles.
• EBITDA Margin 31.1% – Every CFO’s Diwali wish come true.
• Capex ₹141 Cr (H1) – Cash turned into reactors, not regrets.
• Cash Reserves ₹240 Cr – Enough to build another lab or buy one.
• Working Capital Days 100 (↓28) – The inventory gods have finally smiled.

3. Management’s Key Commentary

Naresh Patel (CMD): “We’re building long-term sustainable business rather than chasing opportunities.”
(Translation: Unlike the crypto crowd, we read balance sheets.)

On Battery Chemicals: “Production to start Q4 FY26 after capex completion.”
(Translation: The lithium-ion dream finally leaves the PowerPoint slide.)

On Semiconductor JV: “Indichem in Korea will start contributing by H2 FY27.”
(Translation: Seoulmates in science, not just in sentiment.)

Abhishek Patel (VP Strategy): “Pharma Intermediates grew 27%, Specialty Chemicals 7%.”
(Translation: Old business feeds us, new ones fund our TED Talks.)

Bhavin Shah (CFO): “Gross margins up 1,232 bps to 55.8%.”
(Translation: We printed chemistry money.)

Abhishek Patel: “We churned out low-margin products.”
(Translation: Goodbye cheap intermediates, hello luxury molecules.)

On Margins: “Expect 28–30% EBITDA for FY26.”
(Translation: 30% is the new 20%; we don’t do average anymore.) 😏

On CDMO: “Validation batches sent; commercial production by FY26-end.”
(Translation: Revenue’s in the pipeline — literally.)

On Solar Plant: “5MW commissioned this quarter.”
(Translation: Even our electricity now has EBITDA.)

4. Numbers Decoded

(Summary: Margins expanding faster than chemical reactions. FY26 guidance still sizzling.)

5. Analyst Questions (and Honest Translations)

Q: “Is 30% margin sustainable?”
A: “Yes, product mix magic will keep it there.”
(Translation: We’ve found our formula; don’t ask for the recipe.)

Q: “When will battery chemical revenue start?”
A: “Q4 FY26 partial, full FY27.”
(Translation: Keep calm, electrons are coming.)

Q: “Semiconductor update?”
A: “JV with Korean partner; full ramp-up FY27.”
(Translation: From Surat to Seoul, chemistry goes